DrugPatentWatch Database Preview

Taro Pharm Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for TARO PHARM, and when can generic versions of TARO PHARM drugs launch?

TARO PHARM has fifty-eight approved drugs.

There are seven US patents protecting TARO PHARM drugs. There are three tentative approvals on TARO PHARM drugs.

There are twenty-one patent family members on TARO PHARM drugs in nine countries and fifty-three supplementary protection certificates in fourteen countries.

Summary for Taro Pharm

International Patents:	21
US Patents:	7
Tradenames:	42
Ingredients:	40
NDAs:	58
Patent Litigation for Taro Pharm:	See patent lawsuits for Taro Pharm

Drugs and US Patents for Taro Pharm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro Pharm Inds Ltd	DOXEPIN HYDROCHLORIDE	doxepin hydrochloride	CAPSULE;ORAL	213063-004	Jul 1, 2020	AB	RX	No	No
Taro Pharms	CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE	betamethasone dipropionate; calcipotriene	SUSPENSION;TOPICAL	213269-001	Sep 2, 2020	AB	RX	No	No
Taro Pharm Inds Ltd	OVIDE	malathion	LOTION;TOPICAL	018613-001	Aug 2, 1982		DISCN	Yes	No	7,977,324		Y
Taro Pharm Inds Ltd	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	acetaminophen; butalbital; caffeine	CAPSULE;ORAL	213046-001	Jul 1, 2020	AA	RX	No	No
Taro Pharm Inds	CARBAMAZEPINE	carbamazepine	TABLET, CHEWABLE;ORAL	075687-002	Jul 29, 2002		RX	No	Yes
Taro Pharm Inds	LAMOTRIGINE	lamotrigine	TABLET;ORAL	078525-002	Jan 27, 2009	AB	RX	No	No

Expired US Patents for Taro Pharm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Taro Pharms	PLIAGLIS	lidocaine; tetracaine	CREAM;TOPICAL	021717-001	Jun 29, 2006	5,919,479
Taro Pharms	TOPICORT	desoximetasone	SPRAY;TOPICAL	204141-001	Apr 11, 2013	5,990,100
Taro Pharms	PLIAGLIS	lidocaine; tetracaine	CREAM;TOPICAL	021717-001	Jun 29, 2006	6,528,086

Paragraph IV (Patent) Challenges for TARO PHARM drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Topical Lotion	0.5%		2011-03-16
	Topical Spray	0.25%		2013-12-18

International Patents for Taro Pharm Drugs

Country	Patent Number	Estimated Expiration
European Patent Office	2523660
Israel	187666
Canada	2609579
Brazil	PI0612686
Japan	2013032405
World Intellectual Property Organization (WIPO)	2006130510

Supplementary Protection Certificates for Taro Pharm Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	2013/044	Ireland		PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
1519731	13C0067	France		PRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215
1304992	1390049-3	Sweden		PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
0617614	SPC/GB01/014	United Kingdom		PRODUCT NAME: ALITRETINOIN; REGISTERED: UK EU/1/00/149/001 20001018
1458369	SPC/GB10/005	United Kingdom		PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111
0186118	SPC/GB05/029	United Kingdom		PRODUCT NAME: MESOTRIONE (2-(4-METHYLSULPHONYL-2-NITROBENZOYL)-1,3CYCLOHEXANEDIONE); REGISTERED: AU 2726 20001016; UK 0309 OF 2005 20050218

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Taro
• Taro Pharm Inds
• Taro Pharm Inds Ltd
• Taro Pharms
• Taro Pharms Ireland
• Taro Pharms North